What to do about bridging with novel oral anticoagulants with Dr Seth Bilazarian

Dr Samuel Goldhaber


March 28, 2013

This feature requires the newest version of Flash. You can download it here.

Sharing a rare moment of person-to-person time during the scientific sessions in San Francisco, Dr Seth Bilazarian asks Dr Samuel Goldhaber how he goes about bridging with dabigatran, rivaroxaban, and apixaban.

See also:


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: